Sign up & Download
Sign in

Voriconazole in the treatment of allergic bronchopulmonary aspergillosis in cystic fibrosis.

by L Glackin, G Leen, B Elnazir, P Greally
Irish medical journal ()

Abstract

Allergic bronchopulmonary aspergillosis (ABPA) can cause a significant clinical deterioration in patients with cystic fibrosis. There is very little research in the current literature with regard to alternatives for treatment, apart from long courses of steroids. We conducted a retrospective review of all our patients with ABPA treated with the antifungal voriconazole and found there was a significant drop in IgE levels post treatment as well as a decrease in steroid dosing. The improvement in FEV was not statistically significant; however there was a very wide variation in pre-treatment levels.

Cite this document (BETA)

Readership Statistics

1 Reader on Mendeley
by Discipline
 
by Academic Status
 
100% Post Doc

Sign up today - FREE

Mendeley saves you time finding and organizing research. Learn more

  • All your research in one place
  • Add and import papers easily
  • Access it anywhere, anytime

Start using Mendeley in seconds!

Already have an account? Sign in